A combination of the mother's cells and the placenta's cells make up the mother's bloodstream during pregnancy. The tissue in the uterus that connects the fetus to the mother's blood supply is called the placenta. Throughout the pregnancy, the mother's bloodstream is exposed to these cells. The fetus's DNA and the placental cells' DNA are typically similar. Without endangering the fetus, placental cfDNA analysis offers the possibility of early diagnosis of specific genetic disorders. Additional chromosomal diseases that result from duplicated or missing chromosomal segments may also be screened for during NIPT. The use of NIPT to screen for genetic illnesses resulting from variations in single genes is growing. Researchers anticipate that many more genetic disorders will be able to receive NIPT as genetic testing costs come down and technology advances.
For more details please contact us at +918285108079.
